88. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Donnerstag, 21. April 2022 (Online-Channel 1) 11:00-12:30

Hotline

Late Breaking Clinical Trials I

Vorsitz: D. Dürschmied (Mannheim), A. Elsässer (Oldenburg)

11:00 (V656) Plaque rupture and intact fibrous cap account for different outcomes in patients with acute coronary syndrome – results from the prospective OPTICO-ACS study – Sprecher
    C. Seppelt (Berlin)
11:07 (V657) Plaque rupture and intact fibrous cap account for different outcomes in patients with acute coronary syndrome – results from the prospective OPTICO-ACS study – Diskutant
    D. G. Sedding (Halle (Saale))
11:11 Diskussion
11:15 (V658) Rotational atherectomy vs. modified balloons prior to drug-eluting stent implantation in severely calcified coronary lesions: two-year results of the randomized PREPARE-CALC trial – Sprecher
    G. Richardt (Bad Segeberg)
11:22 (V659) Rotational atherectomy vs. modified balloons prior to drug-eluting stent implantation in severely calcified coronary lesions: two-year results of the randomized PREPARE-CALC trial – Diskutant
    W. Rottbauer (Ulm)
11:26 Diskussion
11:30 (V660) High inter-individual variability in LDL-cholesterol reductions after administration of the siRNA inclisiran – Sprecher
    O. Weingärtner (Jena)
11:37 (V661) High inter-individual variability in LDL-cholesterol reductions after administration of the siRNA inclisiran – Diskutant
    A. M. Zeiher (Frankfurt am Main)
11:41 Diskussion
11:45 (V662) Transseptal Mitral Valve Replacement, Early and Long Term Clinical and Hemodynamic Outcomes of the First 30 Consecutive Cases, HighLife Feasibility Studies in EU/Au/US – Sprecher
    L. Schneider (Ulm)
11:52 (V663) Transseptal Mitral Valve Replacement, Early and Long Term Clinical and Hemodynamic Outcomes of the First 30 Consecutive Cases, HighLife Feasibility Studies in EU/Au/US – Diskutant
    T. Walther (Frankfurt am Main)
11:56 Diskussion
12:00 (V664) “Jena auf Ziel – JaZ” - a prospective cohort study aiming to get all patients with ST-elevation myocardial infarction on EAS/ESC-LDL-C targets – Sprecherin
    U. Makhmudova (Jena)
12:07 (V665) “Jena auf Ziel – JaZ” - a prospective cohort study aiming to get all patients with ST-elevation myocardial infarction on EAS/ESC-LDL-C targets – Diskutantin
    A. Bäßler (Regensburg)
12:11 Diskussion
12:15 (V666) Primary and Extended 12-Month Device Closure Results of the AmplatzerTM AmuletTM IDE Trial of Left Atrial Appendage Occlusion – Sprecher
    B. Schmidt (Frankfurt am Main)
12:22 (V667) Primary and Extended 12-Month Device Closure Results of the AmplatzerTM AmuletTM IDE Trial of Left Atrial Appendage Occlusion – Diskutant
    T. Lewalter (München)
12:26 Diskussion